2022 Hospital Medicine Summit

Earn up to 5.0 AMA, MOC, ANCC, and ACPE credits all in one day!

Saturday, November 12, 2022 Registration & Breakfast: 7:00 AM – 8:00 AM Presentations: 8:00 AM – 1:30 PM

LOCATION

Renaissance Dallas Hotel Stemmons Ballroom 2222 North Stemmons Freeway Dallas, Texas 75207

PROVIDER STATEMENT

This CME activity for ACCME credit is provided by Integrity Continuing Education, Inc. This CE activity for ANCC and ACPE credit is jointly provided by Global Education Group and Integrity Continuing Education, Inc.

DISCLOSURE OF COMMERCIAL SUPPORT

This educational activity is supported by educational grants from AstraZeneca Pharmaceuticals, Daiichi Sankyo, Inc., GlaxoSmithKline, and Salix Pharmaceuticals.

PROGRAM OVERVIEW

Since 2015, the Hospital Medicine Summit (HMS), a multidisciplinary educational event, has been providing an exceptional educational experience that is inclusive of clinicians who manage patients in the acute setting and those who have transitioned to the chronic-care setting. Serving hospitalists, internal medicine physicians, physician assistants, nurse practitioners, pharmacists, and nurses, HMS fulfills a critical need to address significant changes in the healthcare system and the increased demand on these clinicians so they can provide optimal care to patients both in the hospital or acute care setting and when they are discharged into the community healthcare system.

TARGET AUDIENCE

This educational activity has been designed to meet the needs of physicians, physician assistants, nurse practitioners, registered nurses, and pharmacists who practice in hospital, internal medicine, and chronic-care settings.

LEARNING OBJECTIVES

Upon completion of this educational activity, participants should be able to: Keynote: Collaborative Care Between Hospital-based Clinicians and Community Specialists

Learning objectives to come

Session 1 – Taking the Kidneys to Heart: Managing CKD-Related Anemia With Emerging HIF-PHIs

Clarify the disease burden imposed by untreated or undertreated anemia in patients with chronic kidney disease (CKD), including in racially diverse populations
Correlate the pathophysiology of anemia in CKD with viable therapeutic targets
Identify appropriate candidates for emerging CKD-related anemia treatments among patients on or not on dialysis based on efficacy and safety data from recent clinical trials

Session 2 – The Role of the Hospitalist: A Focus on Oncology Treatment Adverse Events

Review the associated grade <3 treatment-related adverse events (trAE) with new and novel anticancer agents
Identify patients presenting with serious trAEs and devise an appropriate management plan

Session 3 – Fireside Chat* Faculty Panel Discussion

Correlate the pathophysiology of anemia in CKD with viable therapeutic targets
Identify patients presenting with cancer trAEs and devise an appropriate management plan
Discuss how to implement a plan of care for patients hospitalized with hepatic encephalopathy (HE) that is consistent with updated evidence-based recommendations

*Learning objectives subject to change for this session Session 4 – Evidence-based Care and Therapeutic Updates to Reduce the Risk for Rapid Progression and Recurrence of Hepatic Encephalopathy

Discuss how to implement a plan of care for patients hospitalized with HE that is consistent with updated evidence-based recommendations
Describe the efficacy and safety of therapies for treatment of acute episodes of overt HE and prevention of their recurrence
Identify crucial components of a transitional care plan to prevent future hospitalizations among patients with HE

KEYNOTE SPEAKER/PROGRAM MODERATOR

Alpesh Amin, MD, MBA, FACC, MACP, SFHM Thomas & Mary Cesario Chair of Medicine Professor of Medicine, Business, Public Health, Nursing Science, and Biomedical Engineering Executive Director, Hospitalist Program Medical Director, Anticoagulation Services University of California, Irvine Irvine, California

FACULTY PRESENTERS

Bradley Christensen, MD Hematologist/Oncologist Texas Oncology Dallas, Texas

Biff F. Palmer, MD, FACP, FASN Professor of Internal Medicine University of Texas Southwestern Medical Center Dallas, Texas

Robert Rahimi, MD Transplant Hepatology Baylor University Medical Center Associate Professor Department of Medicine Texas A&M Health Science Center College of Medicine Liver Consultants of Texas Baylor Charles A. Sammons Cancer Center Dallas, Texas

ACCREDITATION

Physician Continuing Education

Accreditation Statement Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Credit Designation Integrity Continuing Education, Inc. designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Nursing Continuing Education Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This educational activity for 5.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity. Pharmacist Continuing Education Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

Credit Designation Global Education Group designates this continuing education activity for 5.0 contact hours (0.5 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Numbers – 0530-9999-22-234-L01-P, 0530-9999-22-235-L01-P, 0530-9999-22-236-L01-P, 0530-9999-22-237-L01-P, 0530-9999-22-238-L01-P.) This is a knowledge-based activity. Instructions to Receive Credit In order to receive credit for this activity, the participant must complete each session’s pretest, attend each session, and complete the posttest and evaluation form. A statement of credit will be issued only upon receipt of a completed activity evaluation form. For pharmacist/ACPE learners, please check the CPE monitor for your CE credit within 60 days of the activity. Credit cannot be issued after 60 days.

FEE INFORMATION

There is no fee for attending this conference; however, seating is limited. Preregistration does not guarantee seating. We do recommend arriving at the program location early.

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Integrity Continuing Education, Inc. prior to the live event at (855) 835-4004.

CONTACT INFORMATION

For information about ACCME accreditation of this activity, please contact Integrity Continuing Education, Inc. at (855) 835-4004 or cme@integrityce.com. For information about ACPE or ANCC accreditation of this activity, please contact Global Education Group at (303) 395-1782 or cme@globaleducationgroup.com.

DISCLOSURE OF CONFLICTS OF INTEREST

Integrity Continuing Education, Inc. and Global Education Group adhere to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Integrity Continuing Education, Inc. and Global Education Group are required to disclose all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by Integrity Continuing Education, Inc. and Global Education Group in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Integrity Continuing Education, Inc. and Global Education Group to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated. The faculty will disclose all relevant financial relationships with ineligible companies prior to their presentation at the 2022 HMS. The planners and managers at Integrity Continuing Education, Inc. and Global Education Group have no relevant financial relationships to disclose.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. and Global Education Group do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

PRIVACY POLICY

When you participate in an online educational activity sponsored by Integrity Continuing Education, Inc., you will be asked for your name, degree(s), affiliation(s), street address, telephone number and…(continued)

DISCLAIMER

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.